VIR Competitors & Alternatives
Compare Vir Biotechnology Inc with similar stocks in the same industry
Biotechnology
VIR
Main Stock$11.17
Tradestie Score
48
Market Cap
$791.82M
Revenue Growth
195.8%
Analyst Upside
+86.0%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.50
|
$2.02B | - | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.26
|
$2.01B | - | 54 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.02
|
$1.97B | - | 52 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.96
|
$1.92B | - | 51 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$72.10
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$28.64
|
$1.90B | 21.5 | 42 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$30.42
|
$1.84B | - | 51 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.71
|
$1.81B | - | 50 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$13.74
|
$1.78B | - | 37 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.20
|
$1.78B | - | 51 | Compare |
More VIR Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry